Krebs Biochemicals and Industries vs Peers
- Market cap
- ₹122 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹40.85 – ₹76.59
Krebs Biochemicals and Industries ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Krebs Biochemicals & Industries. Its P/E of 22.5 compares with a peer median of 22.5.
Krebs Biochemicals and Industries vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Krebs Biochemicals & Industries | 56.73 | -5.01% | 122 | 22.5 | 2.85 | 14.5% | +18.5% |
| Krebs Biochemicals and Industries | 56.73 | -5.01% | 122 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Krebs Biochemicals and Industries peer comparison — frequently asked questions
Who are Krebs Biochemicals and Industries' competitors?
Krebs Biochemicals and Industries' listed peers in Drug Manufacturers - Specialty & Generic include Krebs Biochemicals & Industries, ranked here by market capitalisation.
How does Krebs Biochemicals and Industries' P/E compare with its peers?
Krebs Biochemicals and Industries trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Krebs Biochemicals and Industries' peers?
By market capitalisation, the largest company in the group is Krebs Biochemicals & Industries at ₹122 crore, against ₹122 crore for Krebs Biochemicals and Industries.
Same Data For Peers
Trade Krebs Biochemicals and Industries With ATS
Track KREBSBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.